
4-tert-Butylbenzoic acid | CAS:98-73-7
4-tert-Butylbenzoic acid
- 名称:对叔丁基苯甲酸 | 4-tert-Butylbenzoic acid
- CAS号:98-73-7
- 别名:PTBBA
- 分子式:C11H14O2
- 分子量:178.23
- EINESC号:202-696-3
产品描述
物理化学性质
熔点 | 164-167 ºC |
---|---|
水溶性 | 0.07 g/L (20 ºC) |
闪点 | 180 ºC |
安全数据
危险品标志 | T;N |
---|---|
危险类别码 | R20/22;R24;R48/20/21/22;R51/53;R |
安全说明书 | S28A;S36/37/39;S45;S61 |
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
mTOR inhibition overcomes primary and acquired resistance to Wee1 inhibition by augmenting replication stress in epithelial ovarian cancers.Fuxia Li et al.American journal of cancer research, 10(3), 908-924 (2020-04-09)
Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs.Ilaria Cascone et al.The EMBO journal, 27(18), 2375-2387 (2008-08-30)
Central memory CD4+ T cells are preferential targets of double infection by HIV-1.Aiman A Haqqani et al.Virology journal, 12, 184-184 (2015-11-13)
FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC.Francesco Morra et al.Oncotarget, 6(14), 12697-12709 (2015-04-18)
SAMHD1 Modulates Early Steps during Human Cytomegalovirus Infection by Limiting NF-κB Activation.Eui Tae Kim et al.Cell reports, 28(2), 434-448 (2019-07-11)
mTOR Overcomes Multiple Metabolic Restrictions to Enable HIV-1 Reverse Transcription and Intracellular Transport.Harry E Taylor et al.Cell reports, 31(12), 107810-107810 (2020-06-25)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!